Ilyas Dhika Virgianna

Qualification Analyst at COMBIPHAR

Ilyas Dhika Virgianna is an experienced professional in the pharmaceutical industry, currently serving as a Qualification Analyst at COMBIPHAR since December 2021, focusing on IQ, OQ, and PQ qualifications for equipment and systems, along with qualification reporting. Prior to this role, Ilyas held positions as a Quality Control Microbiologist at PT Sanbe Farma, managing environmental monitoring, and at PT. Rohto Laboratories Indonesia as a QA Analyst, where responsibilities included similar qualification tasks. Earlier experience includes roles as a QC Analyst at PT. Supra Ferbindo Farma, handling dissolution testing and raw material inspection, and as a QC Inspector at PT. KIMIA FARMA, TBK, overseeing production processes and conducting physical inspections of pharmaceuticals. Ilyas is currently pursuing a Bachelor of Science in Analytical Chemistry at Sekolah Tinggi Analis Bakti Asih, with a foundational education from SMK Chemica Bandung.

Location

Bandung, Indonesia

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


COMBIPHAR

1 followers

Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.